Cellular Dynamics International

Cellular Dynamics International

Cellular Dynamics International is a biotechnology company developing and manufacturing human cells used for drug discovery, toxicity testing, stem cell banking and cell therapy development.

Cellular Dynamics International is a biotechnology company headquartered in Madison, Wisconsin and was founded in 2004 by Craig T. January, Igor Slukvin, James A. Thomson, Robert J. Palay, Thomas M. Palay, and Timothy J. Kamp.

Acquired by Fujifilm

On march 30, 2015 Cellular Dynamics International was acquired by Fujifilm for $307 million.

Funding

Series A

On November 24, 2008 Cellular Dynamics International completed their series A funding round with $18 million in funding from the Wisconsin Alumni Research Foundation and Tactics II Stem Cell Ventures.

Series B

On April 27, 2010 Cellular Dynamics International completed their series B funding round with $40.6 million in funding from Tactics II Stem Cell Ventures (lead investor), Sixth Floor Investors, and Equity Group Investments.

Series B preferred stock financing

On April 7, 2011 Cellular Dynamics International completed their series B preferred stock financing with $30 million in funding from Tactics II Stem Cell Ventures.

Private equity funding round

On November 6, 2012 Cellular Dynamics International completed a private equity round raising $21 million in funding from Tactics II Stem Cell Ventures and Rose Ventures.

Initial public offering (IPO)

On July 24, 2013 Cellular Dynamics International held an initial public offering (IPO) offering 3,846,000 shares of the company at $12 per share. The company raised a total of $43 million during their IPO.

Timeline

July 24, 2013

Initial public offering (IPO)

On July 24, 2013 Cellular Dynamics International held an initial public offering (IPO) offering 3,846,000 shares of the company at $12 per share. The company raised a total of $43 million during their IPO.

November 6, 2012

Private equity funding round

On November 6, 2012 Cellular Dynamics International completed a private equity round raising $21 million in funding from Tactics II Stem Cell Ventures and Rose Ventures.

April 7, 2011

Series B preferred stock financing round

On April 7, 2011 Cellular Dynamics International completed their series B preferred stock financing with $30 million in funding from Tactics II Stem Cell Ventures.

April 27, 2010

Series B funding round

On April 27, 2010 Cellular Dynamics International completed their series B funding round with $40.6 million in funding from Tactics II Stem Cell Ventures (lead investor), Sixth Floor Investors, and Equity Group Investments.

November 24, 2008

Series A funding round

On November 24, 2008 Cellular Dynamics International completed their series A funding round with $18 million in funding from the Wisconsin Alumni Research Foundation and Tactics II Stem Cell Ventures.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Cellular Dynamics International funding round, November 2012
21,041,664
November 6, 2012
Cellular Dynamics International Series B round
Series B round
40,600,000
April 27, 2010
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alex Wehrle

Employee

Anna Maria Swistowska

Employee

Gina Leaming

Employee

Gus Fuldner

Investor

Kwi Hye Kim

Employee

Marissa Stafford

Employee

Melissa Collins

Employee

Miles Lasater

Investor

nicole madfis

Employee

Pat Brooks

Employee

Robert Semmens

Investor

Thomas Novak

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.